Send us Feedback

Cell Therapeutics (CTIC)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cell Therapeutics: Addicted to Reverse Stock Splits
TheStreet.com  Apr 18  Comment 
BOSTON (TheStreet) -- When i it comes to reverse stock splits, I'm willing to give biotech CEOs a single mulligan. We all know drug development is rooted in failure so even well-meaning biotech CEOs land in Wall Street's doghouse. Generosity...
Cell Therapeutics (CTIC) Moves Higher After Securing $15M in Financing
StreetInsider.com  Mar 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+Moves+Higher+After+Securing+%2415M+in+Financing+/8216932.html for the full story.
Cell Therapeutics Enters $15M Loan Financing Agreement with Hercules Technology Growth Capital
Benzinga  Mar 28  Comment 
Cell Therapeutics (NASDAQ: CTIC) announced today it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC) providing for a senior secured term loan of up to $15 million. "The proceeds from this loan...
Cell Therapeutics Board Approves Amendment of Shareholder Rights Plan
Benzinga  Dec 10  Comment 
Cell Therapeutics (NASDAQ: CTIC) today announced that its Board of Directors has approved certain amendments to CTI's existing shareholder rights plan ("Rights Plan") to decrease the exercise price of the preferred stock purchase rights ("Rights")...
Cell Therapeutics Says Study Achieved Endpoint Compared to Other Trials
Benzinga  Dec 5  Comment 
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported on interim results from a cooperative group sponsored Phase 2 clinical trial of brostallicin in combination with cisplatin for the treatment of women with metastatic...
Cell Therapeutics Inc. (CTIC) Narrows Q3 Loss to 38c/Share
StreetInsider.com  Nov 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cell+Therapeutics+Inc.+%28CTIC%29+Narrows+Q3+Loss+to+38cShare/7833002.html for the full story.
Notable 52-Week Highs and Lows of the Day 10/05: (STZ) (PPP) (HD) High; (ZNGA) (CTIC) (MRCY) Low
StreetInsider.com  Oct 5  Comment 
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: Constellation Brands (NYSE: STZ) high of $36.49. Constellation moving higher following a 13 cent earnings beat...
Unusual 11 Mid-Day Movers 10/05: (PPP) (SNSS) (ZNPT) Higher; (CTIC) (MRCY) (ZNGA) Lower
StreetInsider.com  Oct 5  Comment 
Primero Mining Corp. (NYSE: PPP) 33.7% HIGHER; announced today that the Company's Mexican subsidiary has received a positive ruling from the Mexican tax authorities (Servicio de Administracion Tributaria) on its Advance Pricing Agreement ("APA")...
Cell Therapeutics Prices Offering at $1.40/Common Share
Benzinga  Oct 5  Comment 
Cell Therapeutics (NASDAQ: CTIC) today announced the pricing of an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock, offered at a price to the public of $1,000 per share of Series 17 Preferred Stock (the "Offering"). ...
Stocks Hitting 52-Week Lows
Benzinga  Oct 5  Comment 
From Earlier: Cell Therapeutics Announces Proposed Public Offering of 40k Shares Convertible PreferredStock
Benzinga  Oct 4  Comment 
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it intends to offer and sell, subject to market and other conditions, 40,000 shares of its Series 17 Preferred Stock in an underwritten public offering(the "Offering"). ...
Cell Therapeutics (CTIC) to Sell 40k Shares of Convertible Preferred Stock
StreetInsider.com  Oct 4  Comment 




more ▼WIKI ANALYSIS
 

Thinking about getting a kdlnie? the apple kdlnie blog works an assessment to make a example. Learn about its traits and iphone 6 do a comparison of it together with contesting products. at the New iphone same time check out the Ipods many kdlnie accessories the website lists out for you personally.

Retrieved from "http://www.wikinvest.com/stock/Cell_Therapeutics_(CTIC)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki